B. ÇAĞLAYAN Et Al. , "Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice," Experimental Neurology , vol.296, pp.23-31, 2017
ÇAĞLAYAN, B. Et Al. 2017. Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice. Experimental Neurology , vol.296 , 23-31.
ÇAĞLAYAN, B., ÇAĞLAYAN, A. B., BEKER, M. Ç., YALÇIN, E., Beker, M., KELEŞTEMUR, T., ... Sertel, E.(2017). Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice. Experimental Neurology , vol.296, 23-31.
ÇAĞLAYAN, Berrak Et Al. "Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice," Experimental Neurology , vol.296, 23-31, 2017
ÇAĞLAYAN, Berrak Et Al. "Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice." Experimental Neurology , vol.296, pp.23-31, 2017
ÇAĞLAYAN, B. Et Al. (2017) . "Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice." Experimental Neurology , vol.296, pp.23-31.
@article{article, author={Berrak ÇAĞLAYAN Et Al. }, title={Evidence that activation of P2X7R does not exacerbate neuronal death after optic nerve transection and focal cerebral ischemia in mice}, journal={Experimental Neurology}, year=2017, pages={23-31} }